Long-Term Specified Drug Use-results Survey of Betanis Tablets

• Status: Completed
• Trial end date: 2016-09-01
• Target enrollment: 0
• Participant gender: All

Summary

This study is to evaluate the safety and efficacy of long-term use of Betanis (generic name:

mirabegron), and to determine the adherence to treatment with mirabegron.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Astellas Pharma Inc
• Treatments: Mirabegron

Criteria

Inclusion Criteria:

• Patients who administer mirabegron for treatment of urinary urgency, daytime frequency, and urgency incontinence associated with overactive bladder and also who have no treatment history of mirabegron.